Sinovac Biotech Ltd.
No.39 Shangdi Xi Rd
Haidian District
Beijing
100085
China
Tel: 86-10-82890088
Fax: 86-10-62966910
Website: http://www.sinovac.com/
Email: sinovac@sinovac.com
422 articles about Sinovac Biotech Ltd.
-
Sinovac Biotech Ltd. Reports Semi-Annual Results
9/12/2006
-
Sinovac Biotech Ltd. Announces Its Clinical Trial Results Of A Pandemic Influenza (H5N1) Vaccine Are Published By The Lancet
9/8/2006
-
Preliminary Result Of Phase I Clinical Trial Shows That Sinovac Biotech Ltd.'s Pandemic Influenza Vaccine (H5N1) Has High Safety And Immunogenicity Profile
8/28/2006
-
Sinovac Biotech Ltd. Changes Its Contact For Investor Relations
8/1/2006
-
Sinovac Biotech Ltd. Reports Fiscal 2005 Results
7/17/2006
-
Sinovac Biotech Ltd. Files Form 12b-25 With The U.S. Securities And Exchange Commission
7/5/2006
-
Beijing Mayor Visits Sinovac Biotech Ltd.
6/26/2006
-
Sinovac Biotech Ltd. Announces Pandemic Influenza Vaccine Phase I Clinical Trial Preliminary Results
6/19/2006
-
Sinovac Biotech Ltd. Provides Administrative Updates
6/16/2006
-
Sinovac Biotech Ltd. Completes Immunization Schedule In The Phase I Clinical Trial Of Its Proprietary Avian Influenza Vaccine (H5N1)
4/10/2006
-
Sinovac Biotech Ltd. Announces Results Of 2006 Annual Meeting Of Stockholders
3/26/2006
-
Sinovac Biotech Ltd., And LG Life Sciences, Ltd. Announce Distribution Agreement To Market Vaccines In The Peoples Republic Of China
3/13/2006
-
Sinovac Biotech Ltd. To Hold Annual Meeting Of Stockholders And Business Objectives For 2006
2/27/2006
-
Sinovac Biotech Ltd. Reports 18% Sales Growth And 73% Margins For First Six Months Of 2005
1/12/2006
-
Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials
12/21/2005
-
Sinovac Biotech Ltd. Receives Government Funding For Pandemic Flu Vaccine Research And Development
12/9/2005
-
Sinovac Biotech Ltd. Receives Approval To Commence Human Clinical Trials For Pandemic Influenza Vaccine
11/22/2005
-
Sinovac Biotech Ltd. Receives GMP Certification For Seasonal Influenza Vaccine, AnFlu"TM"
10/27/2005
-
The Day In Review: Biotech Adds On Another 16 Points
7/27/2005
-
Sinovac Biotech Ltd. To Test Fully Human Antibody Developed By Medarex, Inc. And Massachusetts Biologic Laboratories For Its Ability To Neutralize The SARS Virus
4/26/2004